focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Regulatory News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

28 Jun 2005 11:40

Quintessentially English PLC28 June 2005 QUINTESSENTIALLY ENGLISH PLC PRELIMINARY RESULTS FOR THE YEAR ENDED 31 DECEMBER 2004 The Company today makes its Preliminary Announcement of its results for theperiod from incorporation on 18 January 2004 to 31 December 2004. The Company had no turnover in the period but incurred costs in its acquisitionsearch. As stated at Admission in March 2004, no remuneration will be paid tothe Directors until an acquisition is made. The loss for the period amounted to £73,194 which includes overheads of £14,841in respect of costs incurred in the period leading up to the AIM flotation ofthe Company which include public relations and consultancy fees, travelexpenses, and professional advisory services. The Company was incorporated principally to take advantage of opportunities toacquire established businesses which could be described as "quintessentiallyEnglish" because of their origin or connection with England. The Company has metand evaluated a large number of prospects but for various reasons these have notprogressed. It continues to seek such acquisitions and has widened itsobjectives and target sectors. Competent management is a key feature of itsrequirements. PROFIT AND LOSS ACCOUNT For the period from incorporation to 31 December 2004 Period ended 31 December 2004 (audited) Note £ Administrative expenses (79,434) OPERATING LOSS 1 (79,434) Interest receivable 6,240 LOSS ON ORDINARY ACTIVITIES BEFORE TAXATION (73,194) TAX ON LOSS ON ORDINARY ACIVITIES 2 - LOSS ON ORDINARY ACTIVITIES AFTER TAXATION £ (73,194) EARNINGS PER SHARE - basic and diluted 3 (0.76)p All amounts relate to continuing operations. There were no recognised gains and losses for 2004 other than those included inthe profit and loss account. BALANCE SHEET As at 31 December 2004 31 December 2004 (audited) Note £ £Fixed Assets Investments 2 CURRENT ASSETS Cash at bank and in hand 222,604 CREDITORS: amounts falling due within one year (16,164) NET CURRENT ASSETS 206,440 TOTAL ASSETS LESS CURRENT LIABILITIES £ 206,442 CAPITAL AND RESERVESCalled up share capital 4 111,769Share premium account 5 167,867Profit and loss account (73,194) EQUITY SHAREHOLDERS' FUNDS 6 £ 206,442 CASH FLOW STATEMENT For the period ended 31 December 2004 Period ended 31 December 2004 (audited) Note £ Net cash flow from operating activities 7 (63,270)Returns on investments and servicing of finance 6,240Acquisitions and disposals (2) CASH OUTFLOW BEFORE FINANCING (57,032) Financing 279,636 INCREASE IN CASH IN THE PERIOD £222,604 1. OPERATING LOSS The operating loss is stated after charging: Period ended 31 December 2004 £ Operating lease rentals:- land and buildings 10,835 Auditors remuneration 5,875 2. TAXATION Period ended 31 December 2004 £Tax on profit on ordinary activities - Factors affecting tax charge for period The tax assessed for the period is higher than the standard rate of corporationtax in the UK applicable to the company (30%). The differences are explained below: Period ended 31 December 2004 £ Loss on ordinary activities before tax (73,194) Loss on ordinary activities multiplied by the relevant standard rate ofcorporation tax in the UK of 30% (21,958) Effects of:Expenses not deductible for tax purposes 433Tax losses carried forward to future periods 21,525 Current tax charge for period (see note above) - Factors that may affect future tax charges At the balance sheet date there are unrelieved management expenses carriedforward of £71,750 available for relief against future relevant profits. 3. EARNINGS PER SHARE The calculation of basic loss per ordinary share for the year is based on theloss of £73,194 and 9,635,094 ordinary shares, being the weighted average numberof ordinary shares in issue during the period. 4.SHARE CAPITAL 31 December 2004 £Authorised 50,000,000 Ordinary shares of 1p each £ 500,000 Allotted, called up and fully paid 11,176,865 Ordinary shares of 1p each £ 111,769 The issued share capital comprises 11,176,865 Ordinary shares, consisting of 200shares of 1p each issued as two £1 subscriber Ordinary shares on incorporationand converted into 1p Ordinary shares on 23 February 2004, 6.666,665 Ordinaryshares of 1p each issued on 24 February 2004 and 4,510,000 Ordinary shares of 1p each issued on 18 March 2004. 5. RESERVES Share premium account £ Premium on shares issued during the period 213,731 Expenses of share issue (45,864) At 31 December 2004 £ 167,867 6. RECONCILIATION OF MOVEMENT IN SHAREHOLDERS' FUNDS 31 December 2004 £ Loss for the period (73,194)Shares issued during the period 111,769Share premium on shares issued (net of expenses) 187,867 Closing shareholders' funds £ 206,442 7.NET CASH FLOW FROM OPERATING ACTIVITIES Period ended 31 December 2004 £Operating Loss (79,434)Increase in creditors 16,164 NET CASH OUTFLOW FROM OPERATIONS £ (63,270) The financial information set out above does not constitute the Company's statutory accounts for the period from incorporation on 18 January 2004 to 31 December 2004 but is derived from those accounts. The Company's registered office is no longer at 11 Cross Keys Close, London W1U2DJ. It has moved to 235 Old Marylebone Road, London NW1 50T. Copies of the Report and Accounts for the period ended 31 December 2004 arebeing sent to shareholders. Further copies will be available from the Company'sregistered office, which is now at 235 Old Marylebone Road, London NW1 50T. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Sep 20237:00 amRNSAGM Statement
1st Sep 202310:29 amRNSUpdate on proposed Share Reorganisation
31st Aug 20237:00 amRNSProposed Share Reorganisation Timetable
22nd Aug 20237:00 amRNSDirectorate Change
17th Aug 20237:00 amRNSBoard Appointment
15th Aug 20231:45 pmRNSDirector/PDMR Shareholding
14th Aug 20237:00 amRNSPosting of Annual Report and confirmation of AGM
3rd Aug 20237:00 amRNSFinal Results
27th Jul 20237:00 amRNSNotice of Results
26th Jul 20232:10 pmRNSHolding(s) in Company
6th Jun 202311:19 amRNSHolding(s) in Company
5th Jun 20234:51 pmRNSHolding(s) in Company
2nd Jun 20232:45 pmRNSHolding(s) in Company
22nd May 20235:33 pmRNSHolding(s) in Company
10th May 20237:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
9th May 20233:42 pmRNSDirector/PDMR Shareholding
21st Apr 20239:48 amRNSHolding(s) in Company
19th Apr 20239:31 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSTrading Update
22nd Mar 20235:57 pmRNSBlock Listing Six Monthly Return
22nd Mar 20233:00 pmRNSHolding(s) in Company
6th Mar 20232:31 pmRNSHolding(s) in Company
27th Jan 20233:03 pmRNSHolding(s) in Company
27th Jan 20239:36 amRNSDirector/PDMR Shareholding
18th Jan 20237:00 amRNSTrading update
16th Jan 202310:56 amRNSHolding(s) in Company
6th Jan 20237:00 amRNSUS expansion update
3rd Jan 202312:34 pmRNSHolding(s) in Company
13th Dec 20224:40 pmRNSSecond Price Monitoring Extn
13th Dec 20224:35 pmRNSPrice Monitoring Extension
13th Dec 202212:01 pmRNSHolding(s) in Company
30th Nov 20229:35 amRNSHolding(s) in Company
25th Nov 20227:00 amRNSReceipt of deferred consideration
24th Nov 20227:00 amRNSHalf-year Report
23rd Nov 20224:41 pmRNSSecond Price Monitoring Extn
23rd Nov 20224:36 pmRNSPrice Monitoring Extension
23rd Nov 20222:05 pmRNSSecond Price Monitoring Extn
23rd Nov 20222:00 pmRNSPrice Monitoring Extension
18th Nov 202212:09 pmRNSHolding(s) in Company
16th Nov 20222:06 pmRNSSecond Price Monitoring Extn
16th Nov 20222:00 pmRNSPrice Monitoring Extension
15th Nov 20227:00 amRNSConfirmation of Results and Investor Presentation
14th Nov 20227:00 amRNSPartnership agreement with Software Provider
8th Nov 20229:04 amRNSLaunch of new all-employee share incentive plan
26th Oct 20222:50 pmRNSResult of AGM
26th Oct 20227:00 amRNSAGM Statement and Notice of Results
11th Oct 20227:00 amRNSScientific Director to present at FIDHC
5th Oct 20227:00 amRNSPositive WHO data received for VISITECT® CD4 test
27th Sep 20227:00 amRNSPosting of Annual Report and confirmation of AGM
20th Sep 202212:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.